NFKB1 and asthma: Further studies suggest that activation of NF-κB is responsible for the pathological progression of neurological disorders, carcinogenesis, immune deficiency, rheumatoid arthritis, atherogenesis, Crohn’s disease, cystic fibrosis, asthma, osteopetrosis, ischemic reperfusion, etc. (Chen et al. 1999).